Interestingly, chronic hypertension has been reported to be associated with tau pathology among APOE e4 carriers [41,42], suggesting a plausibility in mechanism through which hypertension may interact with APOE e4 to influence cognitive function. This evidence concerns the gene MAPT and hypertensive disorder.